Showing results (211-220 of 237) with videos related to
Sort By:
Pageof 24
Cancer Research|March 5, 2003
The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancerJanos L Tanyi, Andrew J Morris, Judith K Wolf, et al.Journal of Medicinal Chemistry|April 13, 2001
Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamidesJ B Thomas, X M Herault, R B Rothman, et al.Journal of Medicinal Chemistry|August 10, 2001
Identification of the first trans-(3R,4R)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activityJ B Thomas, R N Atkinson, R B Rothman, et al.American Journal of Clinical Oncology|February 6, 2004
Second malignancies after chemotherapy and radiotherapy for Hodgkin diseaseGregory M Chronowski, Richard B Wilder, Larry B Levy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinomaR S Freedman, A P Kudelka, J J Kavanagh, et al.The Medical Journal of Australia|December 2, 2006
Tackling the burden of injury in Australasia: developing a binational trauma registryTamzyn M Davey, Cliff W Pollard, Leanne M Aitken, et al.Neuropharmacology|June 23, 2010
A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in ratsXu-Feng Zhang, Char-Chang Shieh, Mark L Chapman, et al.Journal of Medicinal Chemistry|June 27, 2003
Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonistJames B Thomas, Robert N Atkinson, N Ariane Vinson, et al.Journal of Medicinal Chemistry|July 26, 2002
Discovery of an opioid kappa receptor selective pure antagonist from a library of N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphansJames B Thomas, Robert N Atkinson, Nivedita Namdev, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2001
Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breastA Hoque, S M Lippman, I V Boiko, et al.Pageof 24